Eliana Merle

Stock Analyst at UBS

(3.17)
# 1,153
Out of 4,452 analysts
48
Total ratings
45.45%
Success rate
2.75%
Average return
Main Sectors:
Top Industries:

22 Stocks

BridgeBio Pharma
May 28, 2024
Maintains: Buy
Price Target: $51$47
Current: $27.86
Upside: +68.70%
Apellis Pharmaceuticals
May 8, 2024
Maintains: Buy
Price Target: $89$85
Current: $42.00
Upside: +102.38%
Moderna
May 7, 2024
Maintains: Buy
Price Target: $143$151
Current: $140.03
Upside: +7.83%
Kodiak Sciences
Apr 4, 2024
Maintains: Neutral
Price Target: $3$5
Current: $2.81
Upside: +77.94%
Terns Pharmaceuticals
Mar 27, 2024
Maintains: Buy
Price Target: $19$18
Current: $8.20
Upside: +119.51%
BioNTech SE
Mar 27, 2024
Maintains: Neutral
Price Target: $110$101
Current: $92.08
Upside: +9.69%
Madrigal Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $337$410
Current: $277.59
Upside: +47.70%
Akero Therapeutics
Mar 5, 2024
Maintains: Buy
Price Target: $39$42
Current: $23.98
Upside: +75.15%
RAPT Therapeutics
Feb 22, 2024
Downgrades: Neutral
Price Target: $61$10
Current: $3.32
Upside: +201.20%
Revolution Medicines
Dec 20, 2023
Initiates: Buy
Price Target: $40
Current: $38.62
Upside: +3.57%
AnaptysBio
Nov 2, 2023
Maintains: Neutral
Price Target: $28$21
Current: $23.77
Upside: -11.65%
89bio
Oct 12, 2023
Maintains: Buy
Price Target: $36$25
Current: $8.77
Upside: +185.06%
uniQure
May 19, 2023
Maintains: Buy
Price Target: $45$42
Current: $4.89
Upside: +758.90%
CureVac
Jan 19, 2023
Upgrades: Buy
Price Target: $18
Current: $3.67
Upside: +390.46%
Gossamer Bio
Dec 7, 2022
Maintains: Buy
Price Target: $19$8
Current: $0.52
Upside: +1,438.46%
Monte Rosa Therapeutics
Oct 13, 2022
Initiates: Buy
Price Target: $22
Current: $3.83
Upside: +474.41%
REGENXBIO
Jun 23, 2022
Maintains: Buy
Price Target: $51$47
Current: $12.41
Upside: +278.73%
Amicus Therapeutics
May 21, 2021
Initiates: Buy
Price Target: n/a
Current: $10.14
Upside: -
Kymera Therapeutics
May 21, 2021
Initiates: Buy
Price Target: n/a
Current: $33.29
Upside: -
Zentalis Pharmaceuticals
May 21, 2021
Initiates: Buy
Price Target: n/a
Current: $8.84
Upside: -
Arvinas
May 21, 2021
Initiates: Buy
Price Target: n/a
Current: $25.67
Upside: -
Galapagos NV
Aug 19, 2020
Maintains: Neutral
Price Target: n/a
Current: $25.44
Upside: -